Extend Biosciences is a clinical-stage biotechnology company that develops a novel drug delivery platform. It offers D-VITylation, a platform that improves the circulating half-life and bioavailability of peptides and proteins, enabling the development of potent and specific drugs. The company also produces bacterial and virus vaccines, toxoids, and analogous products.